• 中国核心期刊数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

快速检索引用检索图表检索高级检索

中国医药导刊 ›› 2023, Vol. 25 ›› Issue (2): 187-191.

• 论著 • 上一篇    下一篇

阿替普酶溶栓联合依达拉奉右莰醇治疗急性后循环脑梗死疗效及对神经功能相关因子的影响

  田飞, 戴红波   

  1. 济宁市兖州区人民医院, 山东 济宁 272100
  • 收稿日期:2023-01-29 修回日期:2023-02-09 出版日期:2023-02-28 发布日期:2023-02-28

Efficacy of Alteplase Thrombolysis Combined with Edaravone Dexborneol in the Treatment of Acute Posterior Circulation Cerebral Infarction and the#br#      Effect on Neurological Function-Related Factors

  1. People′s Hospital of Yanzhou District, Shandong Jining 272100, China
  • Received:2023-01-29 Revised:2023-02-09 Online:2023-02-28 Published:2023-02-28

摘要: 目的:探讨阿替普酶溶栓联合依达拉奉右莰醇治疗急性后循环脑梗死的疗效,分析其对神经功能相关因子的影响。方法:选取2020年4月至2022年6月本院收治的105例急性后循环脑梗死患者为研究对象,采用随机数字表法分为单一组(n=52)、联合组(n=53)。单一组予以阿替普酶溶栓治疗,联合组予以阿替普酶溶栓+依达拉奉右莰醇治疗。对比两组临床疗效及治疗前后脑血流灌注指标[峰流速(Vp)、平均流速(Vm)、脑血管阻力(CVR)、脉动指数(PI)]、氧化应激指标[谷胱甘肽过氧化物酶(GSH-Px)、超氧化物歧化酶(SOD)、丙二醛(MDA)]、神经功能相关因子[神经元特异性烯醇化酶(NSE)、中枢神经特异性蛋白(S100-β)]水平。对比分析两组患者神经功能缺损程度、日常生活能力。结果:联合组治疗总有效率96.23%,高于单一组84.62%(P<0.05);治疗后联合组Vp、Vm、CVR高于单一组,PI低于单一组(P<0.05);治疗后联合组GSH-Px、SOD水平高于单一组,MDA、NSE、S100-β水平低于单一组(P<0.05);治疗后联合组NIHSS评分低于单一组,BI评分高于单一组(P<0.05)。结论:阿替普酶溶栓联合依达拉奉右莰醇治疗急性后循环脑梗死患者疗效确切,可改善其脑血流灌注,降低氧化应激反应,促进神经功能改善,提高其日常生活能力。

关键词: font-size:medium, ">急性后循环脑梗死;阿替普酶;依达拉奉右莰醇;疗效;神经功能

Abstract: Objective:To investigate the efficacy of alteplase thrombolysis combined with edaravone dexborneol in the treatment of acute posterior circulation cerebral infarction and to analyze its effect on neurological function-related factors. Methods:105 patients with acute posterior circulation cerebral infarction admitted to our hospital from April 2020 to June 2022 were selected for the study and were divided into the single group(n=52) and the combined group(n=53) according to the random number table method. The single group was treated with alteplase thrombolysis and the combined group was treated with alteplase thrombolysis + edaravone dexborneol. The clinical efficacy and cerebral perfusion indexes [peak flow velocity(Vp), mean flow velocity(Vm), cerebrovascular resistance(CVR), pulsatility index(PI)], oxidative stress indexes [glutathione peroxidase(GSH-Px), superoxide dismutase(SOD), malondialdehyde(MDA)], neurological function-related factors [neuron-specific enolase(NSE), central nervous system specific protein(S100-β)] levels of the two groups of patients were compared. The degree of neurological deficits and the daily living ability were compared and analyzed between the two groups of patients. Results:The total effective rate of the combined group was 96.23%, which was higher than that of the single group 84.62%(P<0.05). The level of Vp, Vm and CVR were higher in the combined group than those in the single group and the level of PI was lower than that in the single group after treatment(P<0.05). The GSH-Px and SOD levels in the combined group were higher than those in the single group and the MDA, NSE and S100-β levels were lower than those in the single group after treatment(P<0.05). The combined group after treatment NIHSS score was lower than that of the single group, and the BI score was higher than that of the single group(P<0.05). Conclusion:The efficacy of alteplase thrombolysis combined with edaravone dexborneol in the treatment of patients with acute posterior circulation cerebral infarction is definite, which can improve their cerebral blood perfusion, reduce oxidative stress, promote the improvement of neurological function and enhance their daily living ability.

Key words: font-size:medium, ">Acute posterior circulation cerebral infarction; Alteplase; Edaravone dexborneol; Efficacy; Neurological function

中图分类号: